Effect of Meso Wound Matrix in the Treatment of DFUs

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 5, 2019

Primary Completion Date

May 17, 2022

Study Completion Date

March 1, 2023

Conditions
Diabetic Foot Ulcers (DFUs)
Interventions
DEVICE

Meso Wound Matrix

"Subjects who meet eligibility criteria will receive standard of care and Meso Wound Matrix.~The standard of care therapy in this study is offloading of the DFU, appropriate sharp or surgical debridement, and aggressive infection management with the use of appropriate dressings. Total contact casting or fixed ankle walker will be used for off-loading. Wound Matrix is an acellular scaffold to reinforce and repair soft tissue defects. Subjects may receive up to eight applications of Meso Wound Matrix. Subjects whose study ulcer does not heal after eight applications will receive only SOC treatment for 4 additional weeks."

Trial Locations (3)

15237

D&P Medical Group, Pittsburgh

16226

Foot & Ankle Wellness Clinic, Ford City

33027

Royal Research, Pembroke Pines

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

DSM Biomedical, Inc.

UNKNOWN

lead

SerenaGroup, Inc.

NETWORK

NCT04182451 - Effect of Meso Wound Matrix in the Treatment of DFUs | Biotech Hunter | Biotech Hunter